Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 5/2009

01-10-2009 | Case Report

A boy with membranous nephropathy after allogeneic bone marrow transplantation

Authors: Osamu Motoyama, Yumiko Uchino, Mika Tokuyama, Kikuo Iitaka, Akira Ohara

Published in: Clinical and Experimental Nephrology | Issue 5/2009

Login to get access

Abstract

A 6-year-old boy developed bronchiolitis obliterans organizing pneumonia and nephrotic syndrome 5 months after allogeneic bone marrow transplantation from an unrelated donor for acute lymphoblastic leukemia. His renal biopsy showed membranous nephropathy. He was treated with prednisolone and cyclosporine A. Proteinuria disappeared 3 months after the onset of nephrotic syndrome. To our knowledge, this patient is the youngest case with nephrotic syndrome due to membranous nephropathy after hematopoietic stem cell transplantation.
Literature
1.
Akar H, Keven K, Celebi H, Orhan D, Nergizoglu G, Erbay B, et al. Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation. J Nephrol. 2002;15:79–82.PubMed
2.
Bernis C, Camara R, Sanchez AG, Martinez MA, Selgas R. Nephrotic syndrome in a bone marrow transplant recipient after cyclosporine withdrawal. Nephrol Dial Transplant. 2003;18:2457.CrossRefPubMed
3.
Chan GS, Chim S, Fan YS, Chan KW. Focal segmental glomerulosclerosis after membranous glomerulonephritis in remission: temporal diversity of glomerulopathy after bone marrow transplantation. Human Pathol. 2006;37:1607–10.CrossRef
4.
Chien YH, Lin KH, Lee TY, Lu MY, Tsau YK. Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease. J Formos Med Assoc. 2000;99:503–6.PubMed
5.
Colombo AA, Rusconi C, Esposito C, Bernasconi P, Caldera D, Lazzarino M, et al. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Transplantation. 2006;81:1087–92.CrossRefPubMed
6.
Gomez-Garcia P, Herrera-Arroyo C, Torres-Gomez A, Gomez-Carrasco J, Aljama-Garcia P, Lopez-Rubio F, et al. Renal involvement in chronic graft-versus-host disease: a report of two cases. Bone Marrow Transplant. 1988;3:357–62.PubMed
7.
Haseyama K, Watanabe J, Oda T, Katoh S, Suzuki N, Kudoh T, et al. Nephrotic syndrome related to chronic graft versus host disease after allogeneic bone marrow transplantation in a patient with malignant lymphoma (in Japanese with English abstract). Jpn J Clin Hematol. 1996;37:1383–8.
8.
Ikee R, Yamamoto K, Kushiyama T, Imakiire T, Suzuki S, Miura S. Recurrent nephrotic syndrome associated with graft-versus-host disease. Bone Marrow Transplant. 2004;34:1005–6.CrossRefPubMed
9.
Miyazaki Y, Mori Y, Kishimoto N, Matsumoto N, Zen K, Amakawa R, et al. Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation. Int J Hematol. 2003;78:262–5.CrossRefPubMed
10.
Morisada N, Okita S, Sato T, Miyaji R, Kamizono J, Shimono M, et al. Girl with nephrotic syndrome after peripheral blood stem cell transplantation. Pediatr Int. 2004;46:480–3.CrossRefPubMed
11.
Ohsawa I, Ohi H, Fujita T, Endo M, Ito T, Sawada U, et al. Glomerular and extraglomerular immune complex deposits in a bone marrow transplant recipient. Am J Kidney Dis. 2000;36(E3):1–5.
12.
Oliveira JSR, Bahia D, Franco M, et al. Nephrotic syndrome as a clinical recipient after cyclosporin withdrawal. Bone Marrow Transplant. 1999;23:99–101.CrossRefPubMed
13.
Reddy P, Johnson K, Uberti JP, Reynolds C, Silver S, Ayash L, et al. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;38:351–7.CrossRefPubMed
14.
Sakoda K, Shibuya A, Suzuki H, Saito H, Nemoto T, Tabei K, et al. Nephrotic syndrome in patients after successful myeloablative allogeneic hematopoietic stem cell transplantation: Clinical findings obtained from four transplanted patients (in Japanese with English abstract). Jpn J Nephrol. 2007;49:999–1006.
15.
Sato N, Kishi K, Yagisawa K, Kasama J, Karasawa R, Shimada H, et al. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease. Bone Marrow Transplant. 1995;16:303–5.PubMed
16.
Sato Y, Hara S, Fujimoto S, Yamada K, Sakamaki H, Eto T. Minimal change nephrotic syndrome after allogenic hematopoietic stem cell transplantation. Intern Med. 2004;43:512–5.CrossRefPubMed
17.
Seconi J, Watt V, Ritchie DS. Nephrotic syndrome following allogenic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow transplant. 2003;32:447–50.CrossRefPubMed
18.
Shimokawa T, Sakai M, Kojima Y, Takeyama H. A case of nephrotic syndrome after allogeneic bone marrow transplantation for myelodysplastic syndrome (in Japanese). Med Postgrad. 2003;41:78–82.
19.
Stevenson WS, Nankivell BJ, Hertzberg MS. Nephrotic syndrome after stem cell transplantation. Clin Transplant. 2005;19:141–4.CrossRefPubMed
20.
Tsutsumi C, Miyazaki Y, Fukshima T, Yoshida S, Taguchi J, Miyake C, et al. Membranous nephropathy after allogeneic stem cell transplantation. Int J Hematol. 2004;79:193–7.CrossRefPubMed
21.
Walker JV, Morich D, Anasetti C. Minimal-change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis. 1995;26:532–4.CrossRefPubMed
22.
Yabana M, Takagi N, Kihara M, Muto R, Tamura K, Maemoto S, et al. A case of nephrotic syndrome after bone marrow transplantation (in Japanese with English abstract). Jpn J Nephrol. 1997;39:414–20.
23.
Yorioka N, Taniguchi Y, Shimote K, Komo T, Yamakido M, Hyodo H, et al. Membranous nephropathy with chronic graft-versus-host disease in a bone marrow transplant recipient. Nephron. 1998;80:371–2.CrossRefPubMed
24.
Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267–76.PubMed
25.
Churg J, Sobin LH. Diffuse membranous glomerulonephritis. In: Churg J, Sobin LH, editors. Renal disease. Classification and atlas of glomerular diseases. Tokyo: Igaku-shoin; 1982. p. 54–65.
26.
Bruijn JA, Hogendoorn PCW, Corver WE, van den Broek LJCM, Hoedemaeker PJ, Fleuren GJ. Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol. 1990;79:115–22.CrossRefPubMedPubMedCentral
27.
Neubert R, Delgado I, Abraham K, Schuster C, Helge H. Evaluation of the age-dependent development of lymphocyte surface receptors in children. Life Sci. 1998;62:1099–110.CrossRefPubMed
Metadata
Title
A boy with membranous nephropathy after allogeneic bone marrow transplantation
Authors
Osamu Motoyama
Yumiko Uchino
Mika Tokuyama
Kikuo Iitaka
Akira Ohara
Publication date
01-10-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0178-2

Other articles of this Issue 5/2009

Clinical and Experimental Nephrology 5/2009 Go to the issue

Original Article

High variability of albuminuria in nondiabetic population: the Takahata Study

Original Article

Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats

Case Report

Fatal hemoperitoneum due to rupture of the left gastric artery in a patient with microscopic polyangiitis

Letter to the Editor

Noonan syndrome: crossed fused ectopic kidneys and focal segmental glomerulosclerosis—a rare association

Case Report

Hemolytic uremic syndrome due to homozygous factor H deficiency

Original Article

Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits